471 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Trilogy Capital Inc.

Trilogy Capital Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 471 shares of the healthcare conglomerate’s stock, valued at approximately $233,000.

A number of other institutional investors have also added to or reduced their stakes in UNH. Bell Investment Advisors Inc increased its holdings in shares of UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the last quarter. Harbor Investment Advisory LLC increased its holdings in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the last quarter. Verdence Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 2.1% in the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after acquiring an additional 342 shares during the period. Austin Private Wealth LLC boosted its position in shares of UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after acquiring an additional 111 shares during the period. Finally, Bellecapital International Ltd. boosted its position in shares of UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after acquiring an additional 193 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on UNH. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Finally, Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Trading Up 4.7 %

NYSE:UNH traded up $22.82 on Friday, reaching $509.26. 22,734,197 shares of the stock traded hands, compared to its average volume of 3,685,941. The firm has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.13, a price-to-earnings-growth ratio of 1.48 and a beta of 0.58. The company’s 50 day moving average is $498.34 and its 200-day moving average is $501.96. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.26 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.